Mathew Martoma Insider Trading Conviction: Guilty

This was an obvious conviction. Mathew Martoma and Preet Bharara are both losers though. The winner is Steven A. Cohen. Federal prosecutors have been targeting Cohen for a very long time but they failed to flip Martoma. I am surprised that Martoma didn’t cut a deal with the prosecutors.

insider trading

This conviction doesn’t mean that Cohen’s strong track record is purely because of insider trading. Cohen will continue to generate strong alpha in the coming years. Since he doesn’t have to manage as much capital, his returns will probably go up. Steve Cohen’s investment strategy is very similar to what we do at Insider Monkey. Cohen takes the best ideas of fund managers in his company which is why he was able to deliver such strong returns.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!